Moreover, we further analyzed SORBS2 expression with other clinical parameters that might influence the prognosis of ovarian cancer patients in the Tothill dataset (GSE9899) [13], including patient age and disease stage. This evidence concerns the gene SORBS2 and ovarian carcinoma.